Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001997584-26-000004

Chief Medical Officer sold 55,000 shares at an average $22.62 ($1,244,331)

  • Chief Medical Officer acquired 55,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lechleider Robert · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-02 Exercise or conversion : show line 1 in the form 10b5-1 +55,000 $8.73 $480,150 70,805 D
2026-07-02 Sale : show line 2 in the form 10b5-1 −22,714 $21.95 $498,572 48,091 D
2026-07-02 Sale : show line 3 in the form 10b5-1 −16,214 $22.76 $369,031 31,877 D
2026-07-02 Sale : show line 4 in the form 10b5-1 −16,072 $23.44 $376,728 15,805 D
Open-market sales · 55,000 sh · avg $22.62 · $1,244,331

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-02 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) −55,000 290,000 D
Loading xslF345X06/form4-07072026_090711.xml…